Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns-Reference-Cited by-同舟云学术

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Published:2018-12 Issue: Volume:172 Page:172-178
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Pengo V.^ORCID,Del Ross T.,Ruffatti A.,Bison E.,Cattini M.G.,Pontara E.,Testa S.,Legnani C.,Pozzi N.,Peterle D.,Acquasaliente L.,De Filippis V.,Denas G.

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis;Pengo;J. Thromb. Haemost.,2009

2. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis;de Laat;Blood,2005

3. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity;Ruffatti;Thromb. Haemost.,2006

4. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study;Pengo;Blood,2011

5. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome;Pengo;J. Thromb. Haemost.,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines on the investigation and management of antiphospholipid syndrome;British Journal of Haematology;2024-07-19

2. Thrombosis in Myeloid Malignancies: From CHIP to AML;Cardiovascular & Hematological Disorders-Drug Targets;2024-03

3. The lupus anticoagulant titer is associated with elevated antiphosphatidylserine/prothrombin immunoglobulin‐M isotype antibody levels;International Journal of Laboratory Hematology;2024-02-21

4. Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives;Current Rheumatology Reports;2024-02-19

5. Anti-phosphatidyl-serine/prothrombin (aPS/PT) antibodies are superior predictors of LAC presence and APS diagnoses: A single center study;Clinica Chimica Acta;2024-02